Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome

Sanna Nybacka, Magnus Simrén, Stine Störsrud, Hans Törnblom, Anna Winkvist, Helen M Lindqvist, Sanna Nybacka, Magnus Simrén, Stine Störsrud, Hans Törnblom, Anna Winkvist, Helen M Lindqvist

Abstract

Background: Irritable bowel syndrome (IBS) is a multi-faceted gastrointestinal disorder where food intake often triggers symptoms. Metabolomics may provide mechanistical insights to why responses to dietary modifications are diverse.

Objective: This study aimed to identify metabolite patterns related to dietary intake in patients with IBS, and to identify metabolites driving the separation between responders and non-responders to treatment.

Methods: Participants were randomized to a low fermentable oligo-, di-, monosaccharide and polyol (FODMAP) diet (LFD) or traditional IBS diet (TID) for four weeks. Fasting serum and urine samples pre- and post-intervention were analyzed using 1H nuclear magnetic resonance (NMR) metabolomics. Response to treatment was defined as a reduction in IBS severity scoring system (IBS-SSS) ≥50.

Results: Twenty-five individuals in the LFD (13 responders) and 28 in the TID (14 responders) were included in these post hoc analyses. In endpoint samples, significant decreases in polyols and glucose were seen in the LFD. Post-intervention samples revealed that LFD responders had significantly increased levels of 2-hydroxybuturate and decreased levels of glucose and pantothenic acid compared to non-responders. For the TID, only weak multivariate models were identified and a larger diversity in metabolite response compared to the LFD were noted.

Conclusions: In this study, metabolite patterns between individuals who responded well to an LFD compared to non-responders could be distinguished. This provides new hypotheses for mechanistic actions related to response to dietary modifications, but the results need to be validated in larger cohorts.

Clinical trial registration: This trial was registered at www.clinicaltrials.gov, registry number NCT02107625.

Conflict of interest statement

The authors declared that no competing interests exist.

Figures

Fig 1. CONSORT flow diagram of study…
Fig 1. CONSORT flow diagram of study participants and sample collection.
Fig 2. Observed response (YObs) in relation…
Fig 2. Observed response (YObs) in relation to predicted response (YPred) in the low FODMAP diet and traditional IBS diet in serum and urine samples, colored according to responders and non-responders and labeled 1 = women and 2 = men.
YObs = 1 indicates a perfect match between observed and predicted values and variables with large positive or negative residuals are those differing with respect to the systematic structure captured by the model.

References

    1. Sperber A.D., et al.., Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology, 2021. 160(1): p. 99–114. e3. doi: 10.1053/j.gastro.2020.04.014
    1. Lacy B.E., et al.., Bowel disorders. Gastroenterology, 2016. 150(6): p. 1393–1407. e5. doi: 10.1053/j.gastro.2016.02.031
    1. Schmulson M.J. and Drossman D.A., What Is New in Rome IV. Journal of Neurogastroenterology and Motility, 2017. 23(2): p. 151–163. doi: 10.5056/jnm16214
    1. Simren M., et al.., Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion, 2001. 63(2): p. 108–15. doi: 10.1159/000051878
    1. Bohn L., et al.., Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol, 2013. 108(5): p. 634–41. doi: 10.1038/ajg.2013.105
    1. Monsbakken K.W., Vandvik P.O., and Farup P.G., Perceived food intolerance in subjects with irritable bowel syndrome—etiology, prevalence and consequences. Eur J Clin Nutr, 2006. 60(5): p. 667–72. doi: 10.1038/sj.ejcn.1602367
    1. Staudacher H.M. and Whelan K., Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc, 2016. 75(3): p. 306–18. doi: 10.1017/S0029665116000021
    1. Ohman L., Tornblom H., and Simren M., Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol, 2015. 12(1): p. 36–49. doi: 10.1038/nrgastro.2014.200
    1. McKenzie Y.A., et al.., British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). Journal of Human Nutrition and Dietetics, 2016. 29(5): p. 549–575. doi: 10.1111/jhn.12385
    1. Hookway C., et al.., Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance. Bmj, 2015. 350. doi: 10.1136/bmj.h701
    1. Gibson P.R. and Shepherd S.J., Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. Journal of gastroenterology and hepatology, 2010. 25(2): p. 252–258. doi: 10.1111/j.1440-1746.2009.06149.x
    1. Major G., et al.., Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology, 2017. 152(1): p. 124–133.e2. doi: 10.1053/j.gastro.2016.09.062
    1. Böhn L., et al.., Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology, 2015. 149(6): p. 1399–1407. e2. doi: 10.1053/j.gastro.2015.07.054
    1. McIntosh K., et al.., FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut, 2017. 66(7): p. 1241–1251. doi: 10.1136/gutjnl-2015-311339
    1. Longstreth G.F., et al.., Functional bowel disorders. Gastroenterology, 2006. 130(5): p. 1480–1491. doi: 10.1053/j.gastro.2005.11.061
    1. Francis C.Y., Morris J., and Whorwell P.J., The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary pharmacology & therapeutics, 1997. 11(2): p. 395–402. doi: 10.1046/j.1365-2036.1997.142318000.x
    1. Sousa S., Magalhães A., and Ferreira M.M.C., Optimized bucketing for NMR spectra: Three case studies. Chemometrics and Intelligent Laboratory Systems, 2013. 122: p. 93–102.
    1. Dieterle F., et al.., Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Analytical chemistry, 2006. 78(13): p. 4281–4290. doi: 10.1021/ac051632c
    1. Wishart D.S., et al.., HMDB 3.0—the human metabolome database in 2013. Nucleic acids research, 2012. 41(D1): p. D801–D807. doi: 10.1093/nar/gks1065
    1. Cloarec O., et al.., Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Analytical chemistry, 2005. 77(5): p. 1282–1289. doi: 10.1021/ac048630x
    1. Savorani F., Tomasi G., and Engelsen S.B., icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. Journal of magnetic resonance, 2010. 202(2): p. 190–202. doi: 10.1016/j.jmr.2009.11.012
    1. Worley B. and Powers R., Multivariate analysis in metabolomics. Current Metabolomics, 2013. 1(1): p. 92–107. doi: 10.2174/2213235X11301010092
    1. Jonsson P., et al.., Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. Metabolomics, 2015. 11(6): p. 1667–1678. doi: 10.1007/s11306-015-0818-3
    1. Benjamini Y. and Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal statistical society: series B (Methodological), 1995. 57(1): p. 289–300.
    1. Rossi M., et al.., Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 2018. 16(3): p. 385–391.e1. doi: 10.1016/j.cgh.2017.09.055
    1. Clevers E., et al.., Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome. Nutrition, 2020. 73: p. 110719. doi: 10.1016/j.nut.2020.110719

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する